Catalyst
Slingshot members are tracking this event:
Top-Line data from AstraZeneca's (AZN) Phase 3 ALPS of Roxadustat for Anemia Due to Chronic Renal Failure expected Q2 2018
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AZN | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 20, 2018
Occurred Source:
https://www.astellas.com/en/news/14261
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Roxadustat
